Chemical, Structural, Clinical and Biological details of Antiviral agents ID: DrugRepV_6157



Chemical Information
Antiviral agent IDDrugRepV_6157
Antiviral agent nameSchisandrin A
IUPAC Name(9R,10S)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaene PubChem
SMILES (canonical)CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC PubChem
SMILES (isomeric)C[C@@H]1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3C[C@@H]1C)OC)OC)OC)OC)OC)OC PubChem
Molecular FormulaC24H32O6 PubChem
Molecular Weight (g/mol)416.514 PubChem
InChlInChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3/t13-,14+ PubChem
Structural Information
  
Clinical Information
Biological Information
Secondary Indication Dengue virus (DENV) NA NAWorld Health OrganisationCDC
Secondary Indication (Approaches)Experimental
Secondary Indication (Methods)In-vitro
Secondary Indication (Model system) [cell lines/ animal models]Huh-7
Secondary Indication (Mode of drug delivery) Culture
Secondary Indication (Time of drug delivery) Post infection
Secondary Indication (Duration of drug delivery)6 days
Secondary Indication (Drug concentration)5 mg/kg
Secondary Indication (Cell based assay)Survival assay
Secondary Indication (Change)Decrease
Secondary Indication (Survival rate)80
ReferenceYu JS, Wu YH, Tseng CK, Lin CK, Hsu YC, Chen YH, Lee JC..Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway..Sci Rep. 2017 Mar 24;7:45171. doi: 10.1038/srep45171. PubMed Central PMCID: PMC5364541. PMID:28338050 PubMed
CommentSchisandrin A can e ectively protect mice from DENV infection by reducing disease symptoms and mortality of DENV-infected mice.